Author:
Warr David G.,Grunberg Steven M.,Gralla Richard J.,Hesketh Paul J.,Roila Fausto,Wit Ronald de,Carides Alexandra D.,Taylor Arlene,Evans Judith K.,Horgan Kevin J.
Reference13 articles.
1. The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin;Hesketh;J Clin Oncol,2003
2. Addition of the NK1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy induced nausea and vomiting: results from a randomized, double-blind, placebo controlled trial in Latin America;Poli-Bigelli;Cancer,2003
3. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology;Gralla;J Clin Oncol,1999
4. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists;Hesketh;Eur J Cancer,2003
5. Relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting: analysis of pooled data from two phase III studies of the NK-1 antagonist aprepitant;Grunberg;Proc Am Soc Clin Oncol,2003
Cited by
111 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献